INTRODUCTION
Quinine acts primarily as blood schizontocide; it has little or no effect on sporozoites or preerythrocytic forms of malarial parasites. The alkaloid is gametocytocidal for P.vivax and P. malariae but not for P. falciparum. [1] Because quinine is a weak base, it concentrates in the acidic food vacuoles of P. falciparum where the drug inhibits the non enzymatic polymerization of highly reactive, toxic haem molecules into a non toxic polymer pigment called haemozoin. The failure to inactivate haem kills the parasite via oxidative damage to membrane; digestive proteases and possibly other critical biomolecules. [2, 3] This drug action has been proposed to occur in a two-step process whereby the quinoline binds first to haem, and the 
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The erythrocyte membrane is susceptible to ROS induced lipid peroxidation due to its high content of polyunsaturated lipids. [6, 7] Erythrocyte lipid peroxidation has been extensively used as a basis to investigate the role of oxidative membrane damage in pathological conditions. [8, 9] Extensive lipid peroxidation in biomembranes engenders loss of fluidity, decrease in membrane potential, increase permeability to ions and haemolysis. [10, 11] Furthermore, abnormal susceptibility of erythrocyte membrane to oxidative damage, caused by membrane lipid peroxidation is known to reflect similar abnormalities in organs and tissues. [12, 11] Nevertheless, inhibiton of antioxidant enzymes and depletion of low molecular weight antioxidants engender accumulation of ROS which is particularly relevant in chemotherapy of numerous parasitic infections. [13] [14] [15] Although quinine primary target is the Plasmodia parasites, the present study ascertained level of lipid peroxidation of non-parasitized erythrocytes when non-malarious individuals were administered with quinine.
MATERIALS AND METHODS
Antimalarial Drug: Quinine (BDH, UK), was purchased from Cimpok Pharmaceuticals, Amakhohia, Owerri, Nigeria.
Selection of Volunteers/Experimental Design: Fifteen (15) non-malarious male (59-79 kg) participants, in a group of five (5), of confirmed HbAA genotype between the age brackets of 21-34 years enrolled for this study. Three (3) participants per group were administered with quinine according to the corresponding doses: 1.5, 3.0, 4.5 and 6.0 mg/kg (control; n = 3). At regular time intervals of 3 h for 12 h, blood samples were withdrawn for determination of erythrocyte membrane lipid peroxidation. The Institutional Review Board of the Department of Biochemistry, Imo State University, Owerri, Nigeria, granted approval for this study and all participants involved signed an informed consent form. This study was in accordance with the ethical principles that have their origins in the Declaration of Helsinki.
Collection of Blood Samples/Preparation of Erythrocyte Haemolysate: Five milliliters (5.0 ml) of human venous blood samples of HbAA genotype were collected by venipuncture and stored in Na 2 EDTA anticoagulant tubes. The erythrocytes were washed by centrifugation method as described by Tsakiris et al.,. [16] Within 2 h of collection of blood samples, portions of 1.0 ml of the samples were introduced into centrifuge test tubes containing 3.0 ml of buffer solution pH = 7.4:250 mM tris (hydroxyl methyl) amino ethane-HCl (Tris-HCl)/ 140 mM NaCl/ 1.0 mM MgCl 2 / 10 mM glucose). The erythrocytes were separated from plasma by centrifugation at 1200 g for 10 min and washed three times by the same centrifugation method with the buffer solution. To remove platelets and leucocytes, the sediment was re-suspended in 3.0 ml of phosphatebuffered saline (PBS) solution, pH 7.4, and passed through a column (3.5 cm in a 30 ml syringe) of cellulose-microcrystalline cellulose (ratio w/w 1:1) as described by Kalra et al., . [17] The eluted fraction was passed twice through a new column of cellulosemicrocrystalline cellulose (ratio 1:1 w/w) to obtain erythrocyte suspension sufficiently devoid of leucocytes and platelets. The isolated erythrocytes were lysed by freezing/ thawing as described by Galbraith and Watts, [18] and Kamber et al.,. [19] Hemoglobin-free erythrocyte membrane suspension was prepared using hypotonic lysis procedure as reported by Lam et al., [20] re-suspended in 1.0 ml of the buffer and stored at -70 °C until analyses. [21] Determination of Lipid Peroxidation: Level of erythrocyte membrane lipid peroxidation was measured by the production of thiobarbituric acid reactive substances (TBARS) as described by the modified method of Bernheim et al., [22] as reported by Ojha et al.,. [23] This method used trichloroacetic acid to eliminate interference caused by malondialdehyde precursors. To a reaction mixture of 2.0 ml containing 1.8 ml phosphate buffer (0.1 M; pH = 7.4), 0.2 ml of crude erythrocyte membrane suspension was added. The reaction mixture was incubated at 37 °C in water bath shaker for 1 h. The reaction was terminated by adding 1.0 ml of 10% trichloroacetic acid followed by the addition of 1.0 ml of 0.67% thiobarbituric acid. All the tubes were kept in boiling water bath for 20 min. The tubes were then cooled in ice and centrifuged at 2500 g for 10 min. The resulting supernatant containing TBARS was measured spectrophotometrically (SPECTRONIC 20, LabtechDigital Blood Analyzer®) by taking the sample absorbance at 432 nm against a reagent blank at 24 °C. Estimation of protein standard employed Bradford, [24] method and lipid peroxidation was reported in nmol TBARS/mg protein.
Statistical Analyses:
The results were expressed in terms of arithmetic means (X) ± standard deviation (SD). The statistical significance of the difference between the means was evaluated by Student's-t-test. www.antiox.org damage to membrane structural lipid components. [7, 14] Several studies have demonstrated that oxidative stress in various tissues and blood of experimental animals and humans might be prevented by antioxidant interventions. [26] [27] [28] Therefore, the capacity of quinine to alter the levels of erythrocyte lipid peroxidation is as well connected to the capability of quinine to compromise those antioxidant systems that are responsible for erythrocyte membrane structural integrity. Notable endogenous antioxidant enzymes such as catalase, superoxide dismutase, glutathione peroxidase, glutathione reductase and glutathione-S-transferase have been well-characterized. [21, 23, 29, 30] Also, there are low molecular weight antioxidants such as glutathione, ascorbic acid, carotenoids and α-tocopherol that have been reported by various researchers. [14, 23, [31] [32] [33] [34] Previous in vitro studies by Uwakwe and Ezeh, [35] and Ali and Kadaru, [36] reported that xenobiotics interfered with erythrocyte membrane integrity and stability. Specifically, the reports of Chikezie et al., [37] showed that oral administration of quinine and Fansidar TM inhibited erythrocyte glutathione-S-transferase (GST) activity of male volunteers. In another in vitro study, Chikezie, [38] revealed that erythrocytes incubated in aqueous quinine solution promoted membrane disruption. All these findings points to the fact that quinine, by virtue of its capacity to inhibit the redox enzyme GST, caused accumulation of ROS that may have triggered membrane disruption as a result of lipid peroxidation of structural lipid molecules that are responsible for erythrocyte structural and fuctional integrity. The present findings Figure 1 showed that within the experimental period of 0-12 h, values of erythrocyte membrane lipid peroxidation of the control participants revealed relatively low variability. In addition, erythrocyte membrane of participants administered with quinine exhibited relatively high levels of lipid peroxidation in a dose dependent manner. Generally, within 0-6 h, the four adminstered doses of quinine caused a time dependent elevation of lipid peroxidation. However, further increase in time (t > 6 h) showed decreasing levels of lipid peroxidation. Specifically, the highest level of erythrocyte lipid peroxidation occurred at t = 6 h in participaants dosed with 6.0 mg/kg of quinine. At every given time interval, variations in the levels of lipid peroxidation amongst participants administered with the four doses of quinine showed no significant difference (p > 0.05). However, the levels of lipid peroxidation of participants between 6 and 9 h showed significant difference (p < 0.05). Contrary, levels of lipid peroxidation between 9 and 12 h showed no significant difference (p < 0.05) in this regard. Generally, the levels of erythrocyte lipid peroxidation in the presence of quinine showed 2 phase profile. The first stage showed increasing levels of lipid peroxidation at t < 6 h after drug administeration to the participants, accompanied by the second phase which showed decreasing levels of lipid peroxidation.
RESULTS AND DISCUSION
The present study showed that quinine caused flux in erythrocyte lipid peroxidation which indicated oxidative is supported by pervious reports which stated that oxidative damage of erythrocyte membrane is the primary cause of reduced capacity of the erythrocytes to withstand mechanical and osmotic stress. [39, 40] The recovery of erythrocyte GST, and probably other redox enzymes, from inhibitory effect of quinine with progression of experimental time, [37] could be adduced for decreasing levels of erythrocyte lipid peroxidation (t > 6 h) reported in this study. This same mode and parttern of inhibition of erythrocyte GST by diverse xenobiotics have been reported elsewhere. [41] [42] [43] [44] The present in vivo study confirmed that substances implicated to have compromised/distorted erythrocytes redox equilibrium excacerbates the accumulaton of ROS, and therefore, are indirect promoters of membrane lipid peroxidation.
